Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Key differences at a glance Understanding GLP-1 medications GLP-1 (glucagon-like peptide-1) receptor agonists were originally developed for type 2 diabetes but have revolutionised obesity treatment
Mood or behaviour changes low incidence, with only 1.2% of total safety reports for GLP-1 agonists
Some of these trials have sites in Australia
Emek Blair, Ph.D
With ongoing clinical trials that continue to explore expanded indications, the class of GLP-1 drugs may soon revolutionize how metabolic diseases are being treated in China and around the world
The Muscle Loss Reality Meta-analyses of over 22 randomized controlled trials (Wang L
US$ 26.24
US$ 28.43
US$ 25.63
US$ 23.53
US$ 26.54
US$ 20.19
US$ 26.12
US$ 26.58
US$ 25.12
